Oxford BioDynamics Plc (LON:OBD – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 0.16 and last traded at GBX 0.17, with a volume of 14546039 shares changing hands. The stock had previously closed at GBX 0.17.
Oxford BioDynamics Price Performance
The company has a market cap of £7.29 million, a PE ratio of -0.21 and a beta of 0.42. The business’s 50 day moving average price is GBX 0.20 and its 200-day moving average price is GBX 0.24. The company has a quick ratio of 2.80, a current ratio of 0.88 and a debt-to-equity ratio of 457.97.
Oxford BioDynamics Company Profile
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- The Speed of Light: 5 Stocks Powering AI’s Optical Future
- Dollar General Signals Reversal With 60% Rebound Potential
- Kohl’s Stock Soars After Better-Than-Feared Quarter
- Credo Technologies Paved a Path to a $300 Price Point
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
